Greg Lumpkin

Greg is an experienced financial advisor in the life sciences community. He provides CFO services to start-up life sciences companies, such as WindMIL Therapeutics, Tarsa Therapeutics, Tobira Therapeutics, Cortria, sGC Pharma Corp and CD Diagnostic.

He was VP of Finance at Vitae Pharmaceuticals and PanamaTech. He spent 10 years in various financial roles at McGraw-Hill, Inc.